Effect of Highly Purified Menotrophin and Recombinant Follicle Stimulating (rFSH, Follitrophin Alpha) in Subfertile Female Patients Undergoing IVF on Progesterone Serum Levels During the Follicular Phase and Their Possible Use as Predictors for the Success Rate of Ongoing Pregnancies.

Trial Profile

Effect of Highly Purified Menotrophin and Recombinant Follicle Stimulating (rFSH, Follitrophin Alpha) in Subfertile Female Patients Undergoing IVF on Progesterone Serum Levels During the Follicular Phase and Their Possible Use as Predictors for the Success Rate of Ongoing Pregnancies.

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Apr 2014

At a glance

  • Drugs Menotropin (Primary) ; Follitropin alfa
  • Indications Infertility
  • Focus Pharmacodynamics
  • Acronyms PREDICT
  • Sponsors Ferring Pharmaceuticals
  • Most Recent Events

    • 30 Nov 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2010-019411-37).
    • 04 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 27 Dec 2012 New source identified and integrated (German Clinical Trials Register: DRKS00004146 ).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top